MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.bbmt.2017.04.026

Медицинская библиотека · Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2017

Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.

Heimall Jennifer, Buckley Rebecca H, Puck Jennifer, Fleisher Thomas A, Gennery Andrew R, Haddad Elie, Neven Benedicte, Slatter Mary, Roderick Skinner, Baker K Scott, Dietz Andrew C, Duncan Christine, Griffith Linda M, Notarangelo Luigi, Pulsipher Michael A, Cowan Morton J

СтатьяОбзорConsensus StatementПеревод в очереди

Аннотация

Severe combined immunodeficiency (SCID) is effectively treated with hematopoietic cell transplantation (HCT), with overall survival approaching 90% in contemporary reports. However, survivors are at risk for developing late complications because of the variable durability of high-quality immune function, underlying genotype of SCID, comorbidities due to infections in the pretransplantation and post-transplantation periods, and use of conditioning before transplantation. An international group of transplantation experts was convened in 2016 to review the current knowledge of late effects seen in SCID patients after HCT and to develop recommendations for screening and monitoring for late effects. This report provides recommendations for screening and management of pediatric and adult SCID patients treated with HCT.

Для цитирования: Heimall Jennifer, Buckley Rebecca H, Puck Jennifer, Fleisher Thomas A, Gennery Andrew R, Haddad Elie, Neven Benedicte, Slatter Mary, Roderick Skinner, Baker K Scott, Dietz Andrew C, Duncan Christine, Griffith Linda M, Notarangelo Luigi, Pulsipher Michael A, Cowan Morton J. Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017. DOI: 10.1016/j.bbmt.2017.04.026.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.